Home > Biotechnology and Life Sciences > EPO appeal: global pharmaceutical company

EPO APPEAL: GLOBAL PHARMACEUTICAL COMPANY

In a nutshell: A case that determined the test at the European Patent Office (EPO) for the patentability of treatments for patient sub-groups.

The task: The case related to the patentability of methods of treating new patient sub-populations using a known drug in a known dosage regime.

Result: Successfully represented the client before the Board of Appeal in this landmark case which provides important guidance to other pharmaceutical clients interested in extending their patent protection in this way.